U.S. markets closed

Abbott Laboratories (ABT)

NYSE - NYSE Delayed Price. Currency in USD
119.46+0.44 (+0.37%)
At close: 04:00PM EST
119.59 +0.13 (+0.11%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Short-term KST

Short-term KST

Previous Close119.02
Bid119.26 x 1100
Ask120.08 x 800
Day's Range118.86 - 120.15
52 Week Range89.67 - 120.15
Avg. Volume5,419,595
Market Cap207.285B
Beta (5Y Monthly)0.75
PE Ratio (TTM)36.64
EPS (TTM)3.26
Earnings DateApr 17, 2024 - Apr 22, 2024
Forward Dividend & Yield2.20 (1.84%)
Ex-Dividend DateApr 12, 2024
1y Target Est125.37
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-29% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ABT

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Abbott Laboratories
    Analyst Report: Abbott LaboratoriesAbbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more